These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. A Tool for Patient-Focused Care Regarding Neoadjuvant Chemotherapy for Intrahepatic Cholangiocarcinoma. Cools KS; Glazer ES Ann Surg Oncol; 2021 Apr; 28(4):1874-1875. PubMed ID: 33417116 [No Abstract] [Full Text] [Related]
11. Locoregional Therapy Plus Systemic Chemotherapy in Unresectable Intrahepatic Cholangiocarcinoma. Yang X; Pan J; Zhao H JAMA Oncol; 2020 Jun; 6(6):935. PubMed ID: 32271359 [No Abstract] [Full Text] [Related]
15. Systemic therapy of cholangiocarcinoma: From chemotherapy to targeted therapies. Schweitzer N; Vogel A Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):345-53. PubMed ID: 25966433 [TBL] [Abstract][Full Text] [Related]
16. Dramatic response to trastuzumab and paclitaxel in a patient with human epidermal growth factor receptor 2-positive metastatic cholangiocarcinoma. Law LY J Clin Oncol; 2012 Sep; 30(27):e271-3. PubMed ID: 22851567 [No Abstract] [Full Text] [Related]
17. Long-term advanced cholangiocarcinoma survivor with single-agent capecitabine. Petekkaya I; Gezgen G; Roach EC; Solak M; Gullu I J BUON; 2012; 17(4):796. PubMed ID: 23335544 [No Abstract] [Full Text] [Related]
18. Neoadjuvant Chemotherapy for Intrahepatic Cholangiocarcinoma: A Potential Paradigm Shift in Treatment Sequencing. Ejaz A; Pawlik TM Ann Surg Oncol; 2023 Oct; 30(11):6304-6305. PubMed ID: 37493890 [No Abstract] [Full Text] [Related]
19. Proximal biliary tumors. Brown KM; Geller DA Surg Clin North Am; 2014 Apr; 94(2):311-23. PubMed ID: 24679423 [TBL] [Abstract][Full Text] [Related]